Keyphrases
Platelet-derived Growth factor-BB (PDGF-BB)
100%
Adipogenesis
100%
Orbital Fibroblasts
100%
Graves' Ophthalmopathy
63%
MRNA Expression
27%
Peroxisome Proliferator-activated Receptor
27%
Adipocyte Differentiation
18%
Dasatinib
18%
Oil Red O Staining
18%
Triglycerides
18%
Healthy Controls
9%
Therapeutic Target
9%
Receptor Expression
9%
Interleukin-6
9%
Differentiation Medium
9%
Orbital Tissue
9%
Platelet-derived Growth Factor Receptor (PDGFR)
9%
Signaling Cascades
9%
Hyaluronan Production
9%
Cytokine Production
9%
Tyrosine Kinase Activity
9%
Growth Factor Receptor Tyrosine Kinase
9%
IL-6 Signaling
9%
IL-6 Receptor
9%
Growth Factor Pathway
9%
Tyrosine Kinase Inhibitor
9%
Tyrphostin
9%
Adipose Tissue Expansion
9%
Thyrotropin Receptor
9%
Growth Factor Signaling
9%
Neutralizing Antibodies
9%
Pathological Characteristics
9%
Pharmacological Intervention
9%
Immunology and Microbiology
Adipogenesis
100%
Platelet Derived Growth Factor BB
100%
Fibroblast
100%
Graves' Ophthalmopathy
77%
Platelet Derived Growth Factor
33%
Interleukin-6
33%
Peroxisome
33%
Adipocyte
22%
Cytokine
11%
Adipose Tissue
11%
Neutralizing Antibody
11%
Biochemistry, Genetics and Molecular Biology
Fibroblast
100%
Platelet-Derived Growth Factor
100%
Adipogenesis
100%
Messenger RNA
27%
Interleukin-6
27%
Peroxisome Proliferator-Activated Receptor
27%
Adipocyte
18%
Dasatinib
18%
Triglyceride
18%
Cytokine
9%
Platelet-Derived Growth Factor Receptor
9%
Eicosanoid Receptor
9%
Restylane
9%
Hyaluronan
9%
Neutralizing Antibody
9%
Thyrotropin Receptor
9%
Receptor Tyrosine Kinase
9%
Tyrosine Kinase Inhibitor
9%
Veterinary Science and Veterinary Medicine
Platelet-Derived Growth Factor
100%
Fibroblast
100%
Graves' Ophthalmopathy
63%
Peroxisome Proliferator-Activated Receptor
27%
Adipocyte
18%
Adipose Tissue
9%
Platelet-Derived Growth Factor Receptor
9%
Thyrotropin Receptor
9%